Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Volume
1.1.3. End use
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Volume outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. India Large Volume Parenteral Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. India Large Volume Parenteral Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. India Large Volume Parenteral Market: Application Estimates & Trend Analysis
4.1. India Large Volume Parenteral Market: Key Takeaways
4.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Therapeutic Injections
4.3.1. Therapeutics injections market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Fluid Balance Injections
4.4.1. Fluid balance injections market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nutritious Injections
4.5.1. Nutritious injections market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. India Large Volume Parenteral Market: Volume Estimates & Trend Analysis
5.1. India Large Volume Parenteral Market: Key Takeaways
5.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
5.3. 100 ml
5.3.1. 100 ml market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. 250 ml
5.4.1. 250 ml market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. 500 ml
5.5.1. 500 ml market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. 1,000 ml
5.6.1. 1000 ml market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. 2,000 ml
5.7.1. 2,000 ml market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. India Large Volume Parenteral Market: End Use Estimates & Trend Analysis
6.1. India Large Volume Parenteral Market: Key Takeaways
6.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals and Other Healthcare Facilities
6.3.1. Hospitals and other healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Home Care
6.4.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Market Categorization
7.2.1. B. Braun SE
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Fresenius Kabi AG
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Baxter
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Otsuka Pharmaceutical Co., Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Sichuan Kelun
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Albert David Ltd.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. BML Parenteral Drugs
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
